Alan Lewis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 7,500 shares at $99.11 ($743K) on 2018-08-28, disclosed to the SEC on 2018-08-30.
Open-market sale of $743k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.11 | 7,300 | $724K | 97.3% |
| 2 | $99.12 | 200 | $20K | 2.7% |
| Total | $99.11 avg | 7,500 | $743K | 100% |
| Filing → |
| BMRN | SELL | 2013-12-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2013-02-28 | $1.3M | — | Filing → |
| BMRN | SELL | 2012-11-09 | $702K | — | Filing → |